The Trump administration announced it is rescinding Biden-era guidance requiring hospitals to stabilize patients by ...

The Food and Drug Administration commissioner has committed to reviewing the abortion drug mifepristone after previously ...

CMS has withdrawn a 2022 guidance issued under the Biden administration that reinforced hospitals’ obligations to provide emergency abortion care to women under the Emergency Medical Treatment & Labor ...

Fired employees and conservatives say the gutted research teams’ work aligned with the Trump administration’s “pro-family” messaging.

RFK Jr. is prepared to rework the FDA’s official assessment of the abortion pill mifepristone based at least in part on a questionable report.